Notice2022-00697
National Institute of Mental Health; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 14, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 10 (Friday, January 14, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 10 (Friday, January 14, 2022)]
[Notices]
[Page 2444]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-00697]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Clinical Trials to Test the Effectiveness of
Treatment, Preventive, and Services Interventions (R01,
Collaborative R01, R34).
Date: February 17, 2022.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6143, MSC 9606, Bethesda, MD 20892-9606, 301-443-9699,
<a href="/cdn-cgi/l/email-protection#452730373631202c2b28200528242c296b2b2c2d6b222a33"><span class="__cf_email__" data-cfemail="147661666760717d7a79715479757d783a7a7d7c3a737b62">[email protected]</span></a>.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Early Stage Clinical Trials and Development of
Pharmacologic or Device-Based Interventions.
Date: February 28, 2022.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6143, MSC 9606, Bethesda, MD 20892-9606, 301-443-9699,
<a href="/cdn-cgi/l/email-protection#432136313037262a2d2e26032e222a2f6d2d2a2b6d242c35"><span class="__cf_email__" data-cfemail="751700070601101c1b18103518141c195b1b1c1d5b121a03">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
Dated: January 11, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-00697 Filed 1-13-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 14, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.